iwCLL 2023

iwCLL Program Committee

iwCLL Program Committee

Jennifer R. Brown, MD, PhD
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts, United States


Florence Cymbalista, MD, PhD
Avicenne Hospital
Bobigny, France


Matthew Davids, MD, MMSc
Dana-Farber Cancer Institute
Boston, Massachusetts, United States


Sylvia Deaglio, MD, PhD
University of Turin
Turin, Italy


Barbara Eichhorst, MD
University of Cologne
Cologne, Germany


Michael Hallek, MD, PhD
University of Cologne
Cologne, Germany


Peter Hillmen, MB ChB, PhD
The Leeds Teaching Hospitals
St. James’s University
Leeds, United Kingdom


Arnon Kater, MD, PhD
Amsterdam University Medical Centers
Amsterdam, Netherlands


Stephen Mulligan, MBBS, PhD
Royal North Shore Hospital
Laverty Pathology
Sydney, Australia


Susan O’Brien, MD
University of California, Irvine
Orange, California, United States


Christopher Oakes, MD, PhD
The Ohio State University
Comprehensive Cancer Center
Columbus, Ohio, United States


Tadeusz Robak, MD, PhD
Medical University of Lodz
Lodz, Poland


Anna Schuh, MD, PhD
University of Oxford
Oxford, United Kingdom


John Seymour, MBBS, PhD
Peter MacCallum Cancer Centre
Melbourne, Australia


William Wierda, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas, United States


Adrian Wiestner, MD, PhD
National Institutes of Health (NIH)
Bethesda, Maryland, United States


Jennifer Woyach, MD
The Ohio State University
Comprehensive Cancer Center
Columbus, Ohio, United States


Catherine Wu, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States